U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07619170) titled 'EasiVits Acceptability & Tolerance Study' on May 08.
Brief Summary: In order to achieve metabolic stability, dietary treatment of inborn errors of metabolism (IEM) may require restriction of protein (e.g. phenylketonuria, tyrosinaemia, homocystinuria, organic acidaemias, maple syrup urine disease (MSUD), urea cycle disorders), fat (e.g. fatty acid oxidation disorders) or carbohydrate (e.g. glycogen storage disease). Manipulation of dietary intake potentially reduces micronutrient status, and provision of a comprehensive vitamin and mineral supplement may become an essential adjunct to dietary treatment.
Paediatric Seravit and Frutiv...